These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 9477000
1. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus. Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC. Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000 [Abstract] [Full Text] [Related]
2. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors. Mori A, Noda Y, Mamiya T, Miyamoto Y, Nakajima A, Furukawa H, Nabeshima T. Behav Brain Res; 2001 Feb 15; 119(1):33-40. PubMed ID: 11164523 [Abstract] [Full Text] [Related]
3. Drug discrimination studies with ibogaine. Helsley S, Rabin RA, Winter JC. Alkaloids Chem Biol; 2001 Feb 15; 56():63-77. PubMed ID: 11705117 [Abstract] [Full Text] [Related]
4. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus. Helsley S, Fiorella D, Rabin RA, Winter JC. Pharmacol Biochem Behav; 1998 Feb 15; 59(2):419-25. PubMed ID: 9476990 [Abstract] [Full Text] [Related]
5. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys. Holtzman SG. Pharmacol Biochem Behav; 1993 Feb 15; 44(2):349-55. PubMed ID: 8446667 [Abstract] [Full Text] [Related]
6. Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus. Helsley S, Rabin RA, Winter JC. Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb 15; 23(2):317-26. PubMed ID: 10368872 [Abstract] [Full Text] [Related]
7. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. Shearman GT, Herz A. Eur J Pharmacol; 1982 Aug 27; 82(3-4):167-72. PubMed ID: 6290235 [Abstract] [Full Text] [Related]
8. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey. DeRossett SE, Holtzman SG. J Pharmacol Exp Ther; 1986 May 27; 237(2):437-44. PubMed ID: 3009783 [Abstract] [Full Text] [Related]
9. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs. Glennon RA, Young R, Herndon JL. Pharmacol Biochem Behav; 1993 Aug 27; 45(4):865-9. PubMed ID: 8105490 [Abstract] [Full Text] [Related]
10. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys. Jones HE, Li H, Balster RL. Pharmacol Biochem Behav; 1998 Feb 27; 59(2):413-8. PubMed ID: 9476989 [Abstract] [Full Text] [Related]
11. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists. Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA. J Pharmacol Exp Ther; 1996 Dec 27; 279(3):1130-41. PubMed ID: 8968334 [Abstract] [Full Text] [Related]
13. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047). Singh L, Wong EH, Kesingland AC, Tricklebank MD. Br J Pharmacol; 1990 Jan 27; 99(1):145-51. PubMed ID: 2158832 [Abstract] [Full Text] [Related]
15. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds. Picker MJ. Behav Pharmacol; 1991 Dec 27; 2(6):497-511. PubMed ID: 11224092 [Abstract] [Full Text] [Related]